Publishing research using ab55335? Please let us know so that we can cite the reference in this datasheet.
ab55335 has been referenced in 1 publication.
Herold CI et al.Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing.Clin Cancer Res 17:6061-70 (2011).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"